Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Government Accountability Office. New Drug Development: Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts. GAO-07-49. Washington, DC, 2006. https://www.govinfo.gov/app/details/GAOREPORTS-GAO-07-49
Government Accountability Office. (2006, November 17). GAO-07-49 - New Drug Development: Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts. [Government]. U.S. Government Printing Office. https://www.govinfo.gov/app/details/GAOREPORTS-GAO-07-49
Government Accountability Office. GAO-07-49 - New Drug Development: Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts. U.S. Government Printing Office, (17 Nov 2006), https://www.govinfo.gov/app/details/GAOREPORTS-GAO-07-49
Government Accountability Office, New Drug Development: Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts, GovInfo, (November 17, 2006), https://www.govinfo.gov/app/details/GAOREPORTS-GAO-07-49